These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 7044467

  • 1. A controlled trial of plasma lipid reduction in peripheral atherosclerosis--an interim report.
    Duffield RG, Miller NE, Jamieson CW, Lewis B.
    Br J Surg; 1982 Jun; 69 Suppl():S3-5. PubMed ID: 7044467
    [No Abstract] [Full Text] [Related]

  • 2. Management of the hyperlipidemic patient.
    Berkowitz D.
    Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152
    [No Abstract] [Full Text] [Related]

  • 3. Diet and drug treatment of hyperlipidemia and atherosclerosis.
    Kuo PT.
    Ann Clin Lab Sci (1971); 1972 Jul; 2(4):322-4. PubMed ID: 4342101
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomised controlled trial.
    Duffield RG, Lewis B, Miller NE, Jamieson CW, Brunt JN, Colchester AC.
    Lancet; 1983 Sep 17; 2(8351):639-42. PubMed ID: 6136793
    [Abstract] [Full Text] [Related]

  • 5. Effect of hypolipidemic drugs on serum lipoproteins.
    Carlson LA, Olsson AG.
    Prog Biochem Pharmacol; 1979 Sep 17; 15():238-57. PubMed ID: 224397
    [No Abstract] [Full Text] [Related]

  • 6. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK.
    JAMA; 1975 Jul 21; 233(3):275-7. PubMed ID: 168412
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B, Einarsson K, Leijd B.
    Eur J Clin Invest; 1979 Jun 21; 9(3):185-90. PubMed ID: 113218
    [Abstract] [Full Text] [Related]

  • 11. Corrective therapy of atherogenic hyperlipemia.
    de Gennes JL, Turpin G, Truffert J, Labrousse B.
    Acta Cardiol; 1972 Jun 21; ():Suppl 15:115-3. PubMed ID: 4542781
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hyperlipidemias. Diet and drug therapy].
    Sailer S.
    ZFA (Stuttgart); 1977 Oct 31; 53(30):1829-33. PubMed ID: 930271
    [No Abstract] [Full Text] [Related]

  • 15. [Regression of xanthomas and hypolipidemic drugs].
    Buxtorf JC, Beaumont V, Jacotot B, Beaumont JL.
    Atherosclerosis; 1974 Oct 31; 19(1):1-11. PubMed ID: 4810467
    [No Abstract] [Full Text] [Related]

  • 16. Individualization of treatment of hyperlipoproteinemic disorders.
    Azarnoff DL.
    Med Clin North Am; 1974 Sep 31; 58(5):1129-35. PubMed ID: 4609367
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Management of the hyperlipidaemias.
    Drug Ther Bull; 1980 Mar 28; 18(7):25-8. PubMed ID: 7371502
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapy of lipid disorders.
    Krikler DM.
    J Clin Pathol Suppl (Assoc Clin Pathol); 1973 Mar 28; 5():72-7. PubMed ID: 4582173
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.